Hepatic Steatosis Index Is Associated with Type I Diabetes Complications

被引:17
作者
Tripolino, Cesare [1 ]
Irace, Concetta [2 ]
Cutruzzola, Antonio [2 ]
Parise, Martina [1 ]
Barone, Milena [1 ]
Scicchitano, Caterina [1 ]
Cortese, Claudio [3 ]
Gnasso, Agostino [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Clin & Expt Med, Metab Dis Unit, Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
[3] Tor Vergata Univ, Dept Expt Med & Surg, Rome, Italy
来源
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY | 2019年 / 12卷
关键词
fatty liver; type; 1; diabetes; diabetes complications; FATTY LIVER-DISEASE; ADULT PATIENTS; PREVALENCE;
D O I
10.2147/DMSO.S221969
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. Aim: The aim of the present study was to evaluate the possible association between HSI and complications in T1DM. Methods: Medical records of patients with T1DM were evaluated. Macro- and microvascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. Results: Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. Conclusion: These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice.
引用
收藏
页码:2405 / 2410
页数:6
相关论文
共 50 条
  • [41] Adiponectin as a marker of complications in type I diabetes
    Nevin Mohamed Mamdouh Habeeb
    Omneya Ibrahim Youssef
    Azza Abdel Rahman Saab
    Eman Saleh El Hadidi
    Indian Pediatrics, 2012, 49 : 277 - 280
  • [42] An increased skin microvessel density is associated with neurovascular complications in type 1 diabetes mellitus
    Adamska, Anna
    Pilacinski, Stanislaw
    Zozulinska-Ziolkiewicz, Dorota
    Gandecka, Agnieszka
    Grzelka, Agata
    Konwerska, Aneta
    Malinska, Agnieszka
    Nowicki, Michal
    Araszkiewicz, Aleksandra
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (06) : 513 - 522
  • [43] Dysbiosis in the Development of Type I Diabetes and Associated Complications: From Mechanisms to Targeted Gut Microbes Manipulation Therapies
    Gradisteanu Pircalabioru, Gratiela
    Corcionivoschi, Nicolae
    Gundogdu, Ozan
    Chifiriuc, Mariana-Carmen
    Marutescu, Luminita Gabriela
    Ispas, Bogdan
    Savu, Octavian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) : 1 - 17
  • [44] Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes
    Zib, Ivana
    Jacob, Aris N.
    Lingvay, Ildiko
    Salinas, Karin
    McGavock, Jonathan M.
    Raskin, Philip
    Szczepaniak, Lidia S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (05) : 230 - 236
  • [45] Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank
    Zhang, Xinyu
    Zhao, Shuzhi
    Huang, Yikeng
    Ma, Mingming
    Li, Bo
    Li, Chenxin
    Zhu, Xinyu
    Xu, Xun
    Chen, Haibin
    Zhang, Yili
    Zhou, Chuandi
    Zheng, Zhi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (11):
  • [46] Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes
    Banitalebi, Ebrahim
    Faramarzi, Mohammad
    Nasiri, Samira
    Mardaniyan, Majid
    Rabiee, Vahid
    CLINICAL AND MOLECULAR HEPATOLOGY, 2019, 25 (03) : 294 - 304
  • [47] Retrospective analysis (2009-2017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India
    Kamalraj, Nithyanantham
    Sathishkumar, Madhanagopal
    Arunvignesh, Mani
    Baskar, Viswanathan
    Jebarani, Saravanan
    Amutha, Anandakumar
    Deepa, Mohan
    Rani, Coimbatore Subramanyam Shanthi
    Chandru, Sundaramoorthy
    Unnikrishnan, Ranjit
    Anjana, Ranjit Mohan
    Harish, Mardavada
    Mohan, Viswanathan
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (05)
  • [48] Effect of glycemic control on the Diabetes Complications Severity Index score and development of complications in people with newly diagnosed type 2 diabetes
    Pantalone, Kevin M.
    Misra-Hebert, Anita D.
    Hobbs, Todd M.
    Wells, Brian J.
    Kong, Sheldon X.
    Chagin, Kevin
    Dey, Tanujit
    Milinovich, Alex
    Weng, Wayne
    Bauman, Janine M.
    Burguera, Bartolome
    Zimmerman, Robert S.
    Kattan, Michael W.
    JOURNAL OF DIABETES, 2018, 10 (03) : 192 - 199
  • [49] A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis
    Bjorkstrom, Karl
    Stal, Per
    Holmer, Magnus
    Bengtsson, Bonnie
    Staaf, Annika
    Hoffstedt, Johan
    Hagstrom, Hannes
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (11) : 1420 - 1426
  • [50] Is the Proportion of Carbohydrate Intake Associated with the Incidence of Diabetes Complications?-An Analysis of the Japan Diabetes Complications Study
    Horikawa, Chika
    Yoshimura, Yukio
    Kamada, Chiemi
    Tanaka, Shiro
    Tanaka, Sachiko
    Matsunaga, Satoshi
    Hanyu, Osamu
    Araki, Atsushi
    Ito, Hideki
    Tanaka, Akira
    Ohashi, Yasuo
    Akanuma, Yasuo
    Sone, Hirohito
    NUTRIENTS, 2017, 9 (02)